“…This result was not surprising, because the over-expression of p53 has been reported to be specific to lesions with cellular proliferation or malignancy (18)(19)(20)(21)(22)(23)(24)(25). The over-expression of P53 in mucoepidermoid carcinomas has been well documented with its frequencies ranging from 53% to 67% (25,28,(30)(31), while the sequencing data of the p53 gene have been rather limited, showing some sporadic point mutations (27,29,(32)(33).…”